Interpace Biosciences Statistics
Total Valuation
IDXG has a market cap or net worth of 39.34 million. The enterprise value is 37.62 million.
| Market Cap | 39.34M |
| Enterprise Value | 37.62M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IDXG has 27.70 million shares outstanding. The number of shares has increased by 0.30% in one year.
| Current Share Class | 27.70M |
| Shares Outstanding | 27.70M |
| Shares Change (YoY) | +0.30% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 9.49% |
| Owned by Institutions (%) | 0.52% |
| Float | 1.80M |
Valuation Ratios
The trailing PE ratio is 1.57.
| PE Ratio | 1.57 |
| Forward PE | n/a |
| PS Ratio | 1.09 |
| PB Ratio | 1.69 |
| P/TBV Ratio | 1.69 |
| P/FCF Ratio | 9.58 |
| P/OCF Ratio | 8.83 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.24, with an EV/FCF ratio of 9.17.
| EV / Earnings | 1.54 |
| EV / Sales | 1.04 |
| EV / EBITDA | 7.24 |
| EV / EBIT | 9.01 |
| EV / FCF | 9.17 |
Financial Position
The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.22 |
| Quick Ratio | 1.82 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.19 |
| Debt / FCF | 0.24 |
| Interest Coverage | 101.83 |
Financial Efficiency
Return on equity (ROE) is 225.68% and return on invested capital (ROIC) is 19.40%.
| Return on Equity (ROE) | 225.68% |
| Return on Assets (ROA) | 11.13% |
| Return on Invested Capital (ROIC) | 19.40% |
| Return on Capital Employed (ROCE) | 14.11% |
| Weighted Average Cost of Capital (WACC) | 7.48% |
| Revenue Per Employee | 354,353 |
| Profits Per Employee | 239,676 |
| Employee Count | 102 |
| Asset Turnover | 1.54 |
| Inventory Turnover | 12.73 |
Taxes
| Income Tax | -20.86M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +76.47% in the last 52 weeks. The beta is 0.61, so IDXG's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +76.47% |
| 50-Day Moving Average | 1.59 |
| 200-Day Moving Average | 1.57 |
| Relative Strength Index (RSI) | 40.55 |
| Average Volume (20 Days) | 8,048 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, IDXG had revenue of 36.14 million and earned 24.45 million in profits. Earnings per share was 0.89.
| Revenue | 36.14M |
| Gross Profit | 23.04M |
| Operating Income | 4.18M |
| Pretax Income | 4.00M |
| Net Income | 24.45M |
| EBITDA | 4.65M |
| EBIT | 4.18M |
| Earnings Per Share (EPS) | 0.89 |
Balance Sheet
The company has 2.69 million in cash and 974,000 in debt, with a net cash position of 1.71 million or 0.06 per share.
| Cash & Cash Equivalents | 2.69M |
| Total Debt | 974,000 |
| Net Cash | 1.71M |
| Net Cash Per Share | 0.06 |
| Equity (Book Value) | 23.24M |
| Book Value Per Share | 0.84 |
| Working Capital | 6.02M |
Cash Flow
In the last 12 months, operating cash flow was 4.46 million and capital expenditures -353,000, giving a free cash flow of 4.10 million.
| Operating Cash Flow | 4.46M |
| Capital Expenditures | -353,000 |
| Depreciation & Amortization | 474,000 |
| Net Borrowing | -1.90M |
| Free Cash Flow | 4.10M |
| FCF Per Share | 0.15 |
Margins
Gross margin is 63.75%, with operating and profit margins of 11.55% and 67.64%.
| Gross Margin | 63.75% |
| Operating Margin | 11.55% |
| Pretax Margin | 11.06% |
| Profit Margin | 67.64% |
| EBITDA Margin | 12.86% |
| EBIT Margin | 11.55% |
| FCF Margin | 11.35% |
Dividends & Yields
IDXG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.30% |
| Shareholder Yield | -0.30% |
| Earnings Yield | 62.15% |
| FCF Yield | 10.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on January 15, 2020. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jan 15, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
IDXG has an Altman Z-Score of -5.53 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.53 |
| Piotroski F-Score | 5 |